Commonwealth Equity Services LLC Sells 4,396 Shares of UiPath Inc. (NYSE:PATH)

Commonwealth Equity Services LLC cut its holdings in UiPath Inc. (NYSE:PATH – Get Rating) by 5.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 79,393 shares of the healthcare company’s stock after selling 4,396 shares during the quarter. Commonwealth Equity Services LLC’s holdings in UiPath were worth $1,009,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also added to or reduced their stakes in the stock. Guggenheim Capital LLC boosted its stake in UiPath by 18.8% during the third quarter. Guggenheim Capital LLC now owns 63,663 shares of the healthcare company’s stock worth $803,000 after acquiring an additional 10,062 shares in the last quarter. Parallel Advisors LLC boosted its stake in UiPath by 6.0% during the fourth quarter. Parallel Advisors LLC now owns 20,082 shares of the healthcare company’s stock worth $255,000 after acquiring an additional 1,131 shares in the last quarter. Interchange Capital Partners LLC boosted its holdings in UiPath by 7.9% in the third quarter. Interchange Capital Partners LLC now owns 17,212 shares of the healthcare company’s stock worth $217,000 after acquiring an additional 1,256 shares in the last quarter. Jump Financial LLC bought a new stake in UiPath in the third quarter worth $383,000. Finally, TFG Asset Management GP Ltd boosted its holdings in UiPath by 14.3% in the third quarter. TFG Asset Management GP Ltd now owns 2,000,000 shares of the healthcare company’s stock worth $25,220,000 after acquiring an additional 250,000 shares in the last quarter. Institutional investors own 56.40% of the company’s stock.

Insider Activity

In other news, CFO Ashim Gupta sold 40,000 shares of the firm’s stock in a transaction that occurred on Monday, April 17th. The stock was sold at an average price of $16.18, for a total value of $647,200.00. Following the completion of the sale, the chief financial officer now directly owns 1,624,341 shares of the company’s stock, valued at approximately $26,281,837.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CAO Hitesh Ramani sold 12,000 shares of the company’s stock in a transaction dated Friday, March 17th. The shares were sold at an average price of $17.01, for a total transaction of $204,120.00. Following the completion of the transaction, the chief accounting officer now owns 407,349 shares of the company’s stock, valued at approximately $6,929,006.49. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Ashim Gupta sold 40,000 shares of the company’s stock in a transaction dated Monday, April 17th. The shares were sold at an average price of $16.18, for a total transaction of $647,200.00. Following the transaction, the chief financial officer now directly owns 1,624,341 shares of the company’s stock, valued at approximately $26,281,837.38. The disclosure for this sale can be found here. In the last quarter, insiders sold 92,000 shares of company stock worth $1,529,720. Corporate insiders own 31.88% of the company’s stock.

UiPath Stock Up 7.4 %

Shares of PATH opened at $16.63 on Tuesday. UiPath Inc. has a 52 week low of $10.40 and a 52 week high of $22.30. The company has a market capitalization of $9.27 billion, a price-to-earnings ratio of -27.72 and a beta of 0.69. The stock’s 50-day moving average price is $15.48 and its 200-day moving average price is $14.33.

UiPath (NYSE:PATH – Get Rating) last released its quarterly earnings results on Wednesday, March 15th. The healthcare company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. UiPath had a negative net margin of 31.02% and a negative return on equity of 15.38%. The firm had revenue of $308.55 million during the quarter, compared to the consensus estimate of $278.14 million. As a group, equities analysts anticipate that UiPath Inc. will post -0.33 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently issued reports on PATH. Wells Fargo & Company upped their target price on shares of UiPath from $18.00 to $20.00 and gave the stock an “overweight” rating in a research note on Thursday, March 16th. BMO Capital Markets upped their price target on UiPath from $16.00 to $20.00 in a report on Friday, March 17th. Credit Suisse Group reaffirmed an “outperform” rating and set a $27.50 price target on shares of UiPath in a report on Friday, March 17th. Barclays upped their price target on UiPath from $13.00 to $17.00 and gave the company an “equal weight” rating in a report on Thursday, March 16th. Finally, DA Davidson started coverage on shares of UiPath in a research report on Thursday, April 20th. They set a “neutral” rating and a $16.00 price objective on the stock. Eight analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $19.03.

UiPath Company Profile

(Get Rating)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.